661 related articles for article (PubMed ID: 24661247)
81. T1-weighted and T2-weighted Subtraction MR Images for Glioma Visualization and Grading.
Goryawala M; Roy B; Gupta RK; Maudsley AA
J Neuroimaging; 2021 Jan; 31(1):124-131. PubMed ID: 33253433
[TBL] [Abstract][Full Text] [Related]
82. Non-Gaussian diffusion MR imaging of glioma: comparisons of multiple diffusion parameters and correlation with histologic grade and MIB-1 (Ki-67 labeling) index.
Yan R; Haopeng P; Xiaoyuan F; Jinsong W; Jiawen Z; Chengjun Y; Tianming Q; Ji X; Mao S; Yueyue D; Yong Z; Jianfeng L; Zhenwei Y
Neuroradiology; 2016 Feb; 58(2):121-32. PubMed ID: 26494463
[TBL] [Abstract][Full Text] [Related]
83. Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
Xing Z; You RX; Li J; Liu Y; Cao DR
Clin Neuroradiol; 2014 Dec; 24(4):329-36. PubMed ID: 23994941
[TBL] [Abstract][Full Text] [Related]
84. Non-invasive assessment of heterogeneity of gliomas using diffusion and perfusion MRI: correlation with spatially co-registered PET.
Zhang Y; Lin Y; Xing Z; Yao S; Cao D; Miao WB
Acta Radiol; 2022 May; 63(5):664-671. PubMed ID: 33858207
[TBL] [Abstract][Full Text] [Related]
85. Characterization of prostate lesions as benign or malignant at multiparametric MR imaging: comparison of three scoring systems in patients treated with radical prostatectomy.
Vaché T; Bratan F; Mège-Lechevallier F; Roche S; Rabilloud M; Rouvière O
Radiology; 2014 Aug; 272(2):446-55. PubMed ID: 24937690
[TBL] [Abstract][Full Text] [Related]
86. Comparative study of pulsed-continuous arterial spin labeling and dynamic susceptibility contrast imaging by histogram analysis in evaluation of glial tumors.
Arisawa A; Watanabe Y; Tanaka H; Takahashi H; Matsuo C; Fujiwara T; Fujiwara M; Fujimoto Y; Tomiyama N
Neuroradiology; 2018 Jun; 60(6):599-608. PubMed ID: 29705876
[TBL] [Abstract][Full Text] [Related]
87. Automatic vessel removal in gliomas from dynamic susceptibility contrast imaging.
Emblem KE; Due-Tonnessen P; Hald JK; Bjornerud A
Magn Reson Med; 2009 May; 61(5):1210-7. PubMed ID: 19253390
[TBL] [Abstract][Full Text] [Related]
88. Advanced MR imaging techniques in the evaluation of nonenhancing gliomas: perfusion-weighted imaging compared with proton magnetic resonance spectroscopy and tumor grade.
Sahin N; Melhem ER; Wang S; Krejza J; Poptani H; Chawla S; Verma G
Neuroradiol J; 2013 Oct; 26(5):531-41. PubMed ID: 24199813
[TBL] [Abstract][Full Text] [Related]
89. Introduction of High Throughput Magnetic Resonance T2-Weighted Image Texture Analysis for WHO Grade 2 and 3 Gliomas.
Kinoshita M; Sakai M; Arita H; Shofuda T; Chiba Y; Kagawa N; Watanabe Y; Hashimoto N; Fujimoto Y; Yoshimine T; Nakanishi K; Kanemura Y
PLoS One; 2016; 11(10):e0164268. PubMed ID: 27716832
[TBL] [Abstract][Full Text] [Related]
90. Multiparametric magnetic resonance imaging to differentiate high-grade gliomas and brain metastases.
Mouthuy N; Cosnard G; Abarca-Quinones J; Michoux N
J Neuroradiol; 2012 Dec; 39(5):301-7. PubMed ID: 22197404
[TBL] [Abstract][Full Text] [Related]
91. Prospective glioma grading using single-dose dynamic contrast-enhanced perfusion MRI.
Jain KK; Sahoo P; Tyagi R; Mehta A; Patir R; Vaishya S; Prakash N; Vasudev N; Gupta RK
Clin Radiol; 2015 Oct; 70(10):1128-35. PubMed ID: 26152879
[TBL] [Abstract][Full Text] [Related]
92. Multiparametric Assessment of Treatment Response in High-Grade Soft-Tissue Sarcomas with Anatomic and Functional MR Imaging Sequences.
Soldatos T; Ahlawat S; Montgomery E; Chalian M; Jacobs MA; Fayad LM
Radiology; 2016 Mar; 278(3):831-40. PubMed ID: 26390048
[TBL] [Abstract][Full Text] [Related]
93. Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features.
Punwani S; Rodriguez-Justo M; Bainbridge A; Greenhalgh R; De Vita E; Bloom S; Cohen R; Windsor A; Obichere A; Hansmann A; Novelli M; Halligan S; Taylor SA
Radiology; 2009 Sep; 252(3):712-20. PubMed ID: 19635832
[TBL] [Abstract][Full Text] [Related]
94. Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: a preliminary investigation in terms of identification and segmentation.
Assefa D; Keller H; Ménard C; Laperriere N; Ferrari RJ; Yeung I
Med Phys; 2010 Apr; 37(4):1722-36. PubMed ID: 20443493
[TBL] [Abstract][Full Text] [Related]
95. Grading glial tumors with amide proton transfer MR imaging: different analytical approaches.
Sakata A; Okada T; Yamamoto A; Kanagaki M; Fushimi Y; Okada T; Dodo T; Arakawa Y; Schmitt B; Miyamoto S; Togashi K
J Neurooncol; 2015 Apr; 122(2):339-48. PubMed ID: 25559689
[TBL] [Abstract][Full Text] [Related]
96. Integrating diffusion kurtosis imaging, dynamic susceptibility-weighted contrast-enhanced MRI, and short echo time chemical shift imaging for grading gliomas.
Van Cauter S; De Keyzer F; Sima DM; Sava AC; D'Arco F; Veraart J; Peeters RR; Leemans A; Van Gool S; Wilms G; Demaerel P; Van Huffel S; Sunaert S; Himmelreich U
Neuro Oncol; 2014 Jul; 16(7):1010-21. PubMed ID: 24470551
[TBL] [Abstract][Full Text] [Related]
97. Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas.
Di Costanzo A; Pollice S; Trojsi F; Giannatempo GM; Popolizio T; Canalis L; Armillotta M; Maggialetti A; Carriero A; Tedeschi G; Scarabino T
Radiol Med; 2008 Feb; 113(1):134-43. PubMed ID: 18338133
[TBL] [Abstract][Full Text] [Related]
98. Comparison of BOLD cerebrovascular reactivity mapping and DSC MR perfusion imaging for prediction of neurovascular uncoupling potential in brain tumors.
Pillai JJ; Zacà D
Technol Cancer Res Treat; 2012 Aug; 11(4):361-74. PubMed ID: 22376130
[TBL] [Abstract][Full Text] [Related]
99. Diffusion-weighted MR imaging for the differentiation of true progression from pseudoprogression following concomitant radiotherapy with temozolomide in patients with newly diagnosed high-grade gliomas.
Lee WJ; Choi SH; Park CK; Yi KS; Kim TM; Lee SH; Kim JH; Sohn CH; Park SH; Kim IH
Acad Radiol; 2012 Nov; 19(11):1353-61. PubMed ID: 22884399
[TBL] [Abstract][Full Text] [Related]
100. Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings.
Stadnik TW; Chaskis C; Michotte A; Shabana WM; van Rompaey K; Luypaert R; Budinsky L; Jellus V; Osteaux M
AJNR Am J Neuroradiol; 2001 May; 22(5):969-76. PubMed ID: 11337344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
